Holen Sie sich die Stockscreener-App
209.16
0.78%
1.3445
Axsome Therapeutics Inc Aktie (AXSM) Neueste Nachrichten
Hsbc Holdings PLC Sells 12,653 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Is Axsome Therapeutics (NASDAQ:AXSM) Entering A Turning Point? - Kalkine Media
33,554 Shares in Axsome Therapeutics, Inc. $AXSM Bought by Readystate Asset Management LP - MarketBeat
Axsome Therapeutics (AXSM) Investor Outlook: Unveiling a 38% Upside Potential Amidst Rapid Growth in CNS Therapies - DirectorsTalk Interviews
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Seven Fleet Capital Management LP Grows Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
12,293 Shares in Axsome Therapeutics, Inc. $AXSM Bought by Public Employees Retirement System of Ohio - MarketBeat
Corient Private Wealth LP Makes New $1.26 Million Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome therapeutics COO Mark Jacobson sells $2.08m of company stock - Investing.com Nigeria
Axsome Therapeutics, Inc. $AXSM Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Axsome Therapeutics (AXSM) Institutional Ownership 2026 - MarketBeat
Axsome Therapeutics (NASDAQ:AXSM) COO Sells $2,086,500.00 in Stock - MarketBeat
Axsome Therapeutics (AXSM) COO sells 10,000 shares in pre-set trading plan - Stock Titan
Planned $2.1M Axsome Therapeutics (AXSM) stock sale set under pre-arranged trading plan - Stock Titan
Wells Fargo Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $256 - moomoo.com
Analysts Conflicted on These Healthcare Names: Axsome Therapeutics (AXSM), BioMarin Pharmaceutical (BMRN) and Envista Holdings (NVST) - The Globe and Mail
Axsome Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Legal & General Group Plc Makes New $8.10 Million Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Van ECK Associates Corp Has $7.17 Million Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
20,091 Shares in Axsome Therapeutics, Inc. $AXSM Bought by Alyeska Investment Group L.P. - MarketBeat
Axsome Begins Phase III Study on AXS-05 for Smoking Cessation - Yahoo Finance
Axsome Therapeutics' Auvelity Could Drive Revenue Beats After Launch in Alzheimer's Agitation, RBC Says - marketscreener.com
Wellington Management Group LLP Has $160.06 Million Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics Insider Ups Holding During Year - Moomoo
HC Wainwright Reaffirms "Buy" Rating for Axsome Therapeutics (NASDAQ:AXSM) - MarketBeat
Axsome doses first patient in phase 3 smoking cessation trial - Investing.com
Axsome Therapeutics Starts Phase 3 Trial of AXS-05 for Smoking Cessation - marketscreener.com
Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation - Yahoo Finance
Axsome Therapeutics, Inc. (AXSM) Stock Analysis: A Biotech Gem with 43% Upside Potential - DirectorsTalk Interviews
Jupiter Topco LLC Makes New Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Jefferies Financial Group Inc. Invests $6.27 Million in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Bank of New York Mellon Corp Acquires Shares of 197,226 Axsome Therapeutics, Inc. $AXSM - MarketBeat
Hsbc Holdings PLC Invests $13.67 Million in Axsome Therapeutics, Inc. $AXSM - MarketBeat
28,826 Shares in Axsome Therapeutics, Inc. $AXSM Purchased by Seven Fleet Capital Management LP - MarketBeat
Panoramic Capital LLC Purchases New Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Ieq Capital LLC Makes New $1.89 Million Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Algert Global LLC Sells 40,125 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
OMERS ADMINISTRATION Corp Takes Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
B. Metzler seel. Sohn & Co. AG Invests $2.26 Million in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Great Lakes Advisors LLC Invests $1.65 Million in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Enterprise value to EBIT forward of Axsome Therapeutics, Inc. – MUN:19X - TradingView
Axsome Therapeutics’ Q4 Numbers Beat Wall Street Expectations: Analyst Sees Over 23% Upside For Stock - Stocktwits
AXSM Stock Is Rising Today After Wall Street’s Positive Stance Despite Mixed Q1 – What's Behind The Optimism? - Stocktwits
AXSM Stock In Spotlight Ahead Of Key FDA Verdict On Alzheimer’s Drug This Week - Stocktwits
Zacks Research Upgrades Axsome Therapeutics (NASDAQ:AXSM) to "Hold" - MarketBeat
Lisanti Capital Growth LLC Acquires Shares of 20,825 Axsome Therapeutics, Inc. $AXSM - MarketBeat
Eagle Health Investments LP Invests $15.92 Million in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Enterprise value to EBITDA forward of Axsome Therapeutics, Inc. – SWB:19X - TradingView
Axsome Therapeutics Inc (AXSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Here’s How Much You Would Have Made Owning Axsome Therapeutics Stock In The Last 5 Years - Sahm
Pallas Capital Advisors LLC Acquires Shares of 40,511 Axsome Therapeutics, Inc. $AXSM - MarketBeat
TimesSquare Capital Management LLC Takes Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
AXSM Stock Advances On CEO’s Pipeline Claim: One New Drug Filing Yearly Through 2030 - Stocktwits
OneDigital Investment Advisors LLC Makes New Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Significant 33.58% Upside Potential with Strong Buy Ratings - DirectorsTalk Interviews
GSA Capital Partners LLP Makes New $2.31 Million Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. (AXSM) Latest Stock News & Headlines - Yahoo Finance
0.71%
2.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):